Product Information
WELLBUTRIN XL 150 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $69.9388 per EA under NDC 00187073030. Its NADAC has been published 619 times since Nov 28, 2013.
FDA first approved this application on Aug 28, 2003. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the bupropion hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
Bausch Health US LLCNDC
00187073030
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021515FDA Approved
8/28/2003
TE Code
AB3
On Market Since
8/29/2003
Pharmacological Classes
Price Statistics
The NADAC for WELLBUTRIN XL 150 MG TABLET has been published 619 times since Nov 28, 2013, and over the history we have for it it has risen 622.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $69.9388 per EA |
|---|---|
| All-time high | $70.0926 (May 14, 2025) |
| All-time low | $9.6797 (Nov 28, 2013) |
| Median price | $43.7505 |
| Average price | $44.6905 |
| Largest weekly change | +20.9% (Oct 8, 2014) |
| Weeks tracked | 619 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+20.1%
5Y
+38.0%
All
+622.5%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bupropion hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoketone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of WELLBUTRIN XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for WELLBUTRIN XL 150 MG TABLET, manufactured by Bausch Health US LLC, is $69.9388 per EA (NDC 00187073030), effective Oct 1, 2025.
How has the price of WELLBUTRIN XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for WELLBUTRIN XL 150 MG TABLET has risen 622.5%. It has been tracked across 619 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for WELLBUTRIN XL 150 MG TABLET?
Since Nov 28, 2013, the NADAC for WELLBUTRIN XL 150 MG TABLET has ranged from a low of $9.6797 (Nov 28, 2013) to a high of $70.0926 (May 14, 2025), with a median of $43.7505 per EA.
Are there cheaper alternatives to WELLBUTRIN XL 150 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 99% below WELLBUTRIN XL 150 MG TABLET.
Who manufactures WELLBUTRIN XL 150 MG TABLET?
WELLBUTRIN XL 150 MG TABLET (NDC 00187073030) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.